Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Outcome of Hodgkin Lymphoma after Progression Following Autologous Stem Cell Transplantation

Joseph M. Connors, Alina S Gerrie, MD, Maryse M Power, MD, Kerry J Savage, MD

Blood (2016) 128 (22): 2994.

https://doi.org/10.1182/blood.V128.22.2994.2994

Published: 2016

Journal Articles

Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide

Amir Siddiqui, Donna E. Hogge, MD PhD, Thomas J. Nevill, MD, Stephen H. Nantel, MD FRCPC, Michael J Barnett, BMBS, Raewyn Broady, MBChB, Donna L. Forrest, MD, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Maryse M Power, MD, Kevin W. Song, MD, Cynthia L. Toze, MD MHSc, FRCPC, Yasser Abou Mourad, MD, Heather J. Sutherland, MD PhD, Alina S. Gerrie, MD MPH, FRCPC, David Sanford, MD FRCPC

Blood (2016) 128 (22): 2814.

https://doi.org/10.1182/blood.V128.22.2814.2814

Published: 2016

Journal Articles

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Katie Y. Zhu, BHSc, Kevin W. Song, MD, Joseph M Connors, MD, Tracy Tucker, PhD FCCMG, Graham W. Slack, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD FRCPC, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD FRCPC, Maryse M Power, MB, MRCPI, FRCPath, David Sanford, MD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Heather J. Sutherland, MD PhD FRCPC, Laurie H. Sehn, Raewyn Broady, MBChB, FRACP, Alina S. Gerrie, MD MPH, FRCPC

Blood (2016) 128 (22): 1113.

https://doi.org/10.1182/blood.V128.22.1113.1113

Published: 2016

Journal Articles

A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Fong Chun Chan, Anja Mottok, Alina S Gerrie, MD, Maryse M Power, MD, Kerry J Savage, MD, Marcel Nijland, MD, Arjan Diepstra, MD PhD, Anke Van den Berg, PhD, Joseph M. Connors, Randy D. Gascoyne, Sohrab P. Shah, David W. Scott, Christian Steidl

Blood (2016) 128 (22): 1093.

https://doi.org/10.1182/blood.V128.22.1093.1093

Published: 2016

Journal Articles

Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia

Blood (2016) 128 (22): 5852.

https://doi.org/10.1182/blood.V128.22.5852.5852

Published: 2016

Journal Articles

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes

Musa Alzahrani, MBBS, ABIM, Maryse M Power, MD, Emilie Nevill, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Raewyn Broady, MBChB, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, FRCPC, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD FRCPC, David Sanford, MD FRCPC, Heather J. Sutherland, MD PhD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Kevin W. Song, MD, Kevin W. Song, MD, Thomas J. Nevill, MD FRCPC, Sujaatha Narayanan

Blood (2016) 128 (22): 4662.

https://doi.org/10.1182/blood.V128.22.4662.4662

Published: 2016

Journal Articles

Pediatric-Based Versus Adult Treatment Protocols in Young Adults (18-40 years) with Standard Risk Acute Lymphoblastic Leukemia: The BC Cancer Agency Experience

David Simon Kliman, MBBS, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD FRCPC, Alina S. Gerrie, MD MPH, FRCPC, Donna E. Hogge, MD PhD FRCPC, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD FRCPC, Maryse M Power, MB, MRCPI, FRCPath, Kevin Song, MD FRCPC, Heather J. Sutherland, MD PhD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Yasser Abou Mourad, MD FRCPC

Blood (2015) 126 (23): 3770.

https://doi.org/10.1182/blood.V126.23.3770.3770

Published: 2015

Journal Articles

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Sebastian J. Swic, Alexander G. T. MacPhail, Chinmay B. Dalal, MD, Steven J.T. Huang, BMLSc, Alina S. Gerrie, MD FRCPC, Thomas J. Nevill, MD, Heather J. Sutherland, MD PhD FRCPC, Raewyn Broady, MBChB, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Kevin Song, MD, Yasser R Abou Mourad, MD FRCPC, Donna E. Hogge, MD PhD FRCPC, Maryse M. Power, MD MRCPI, FRCPath, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD, Sean S Young, PhD DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD FCCMG, Cynthia L. Toze, MD FRCPC

Blood (2014) 124 (21): 2549.

https://doi.org/10.1182/blood.V124.21.2549.2549

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors

Anish Nair, MD, Michael J Barnett, BM, Donna E. Hogge, MD PhD, Kevin Song, MD, Cynthia L. Toze, MD FRCPC, Stephen H. Nantel, MD FRCPC, Maryse M Power, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Heather J. Sutherland, MD PhD FRCPC, Thomas J. Nevill, MD FRCPC, Yasser R Abou Mourad, MD FRCPC, Alina S. Gerrie, MD FRCPC, Donna L. Forrest, MD

Blood (2014) 124 (21): 1250.

https://doi.org/10.1182/blood.V124.21.1250.1250

Published: 2014

Journal Articles

Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation

Fong Chun Chan, MSc, Anja Mottok, MD, Alina S. Gerrie, MD MPH, Maryse M. Power, MD MRCPI, FRCPath, Kerry J. Savage, MDMSc, Joseph M. Connors, Randy D. Gascoyne, MD, Sohrab P. Shah, PhD, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2014) 124 (21): 136.

https://doi.org/10.1182/blood.V124.21.136.136

Published: 2014

Journal Articles

Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia

Blood (2013) 122 (21): 1788.

https://doi.org/10.1182/blood.V122.21.1788.1788

Published: 2013

Journal Articles

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Chinmay B. Dalal, MD, Chandrakala Shanmukhaiah, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, FRCPC, Donna L. Forrest, MD, FRCPC, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, FRCPC, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, MRCPI, FRCPath, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Yasser R Abou Mourad, MD, FRCPC, John D. Shepherd, MD, FRCPC, Sean S Young, PhD, DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD, FCCMG, Cynthia L. Toze, MD, MHSc, FRCPC

Blood (2012) 120 (21): 4132.

https://doi.org/10.1182/blood.V120.21.4132.4132

Published: 2012

Journal Articles

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Satish Krishnan, MBBS, MRCP, FRCPath, Huihua Li, Yasser R Abou Mourad, Michael J. Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna E. Hogge, MD, PhD

Blood (2011) 118 (21): 2561.

https://doi.org/10.1182/blood.V118.21.2561.2561

Published: 2011

Journal Articles

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Cynthia L. Toze, MD, FRCPC, Chinmay B. Dalal, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, Yasser Abou Mourad, MD, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, FRCPath, Sujaatha Narayanan, MD, Tanya L. Gillan, PhD, FCCMG, Clayton A. Smith, MD, FRCPC, John D. Shepherd, MD, FRCPC

Blood (2011) 118 (21): 3100.

https://doi.org/10.1182/blood.V118.21.3100.3100

Published: 2011

Journal Articles

Safety and Efficacy of Posaconazole for the Treatment of Invasive Fungal Infections After Failure of One Prior Line of Therapy

Shariq Haider, MD FRCPC FACP CCST(UK), Laverdiere Michel, MD, Maryse M. Power, MD, FRCPath, Coleman Rotstein, MD, FRCPC, FACP, Shahid Husain, MD, MS, Jeffrey H. Lipton, MD, PhD, Karen Doucette, FRCPC, MSc, Peter Phillips, MD FRCPC, Andre Galarneau, Jean-Francois Pouliot, PhD

Blood (2011) 118 (21): 4479.

https://doi.org/10.1182/blood.V118.21.4479.4479

Published: 2011

Journal Articles

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Alina S. Gerrie, MD, FRCPC, Maryse M. Power, MD, FRCPath, Kerry J. Savage, MD MSc, John D. Shepherd, MD, FRCPC, Joseph M. Connors, MD

Blood (2011) 118 (21): 2022.

https://doi.org/10.1182/blood.V118.21.2022.2022

Published: 2011

Journal Articles

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Adisak Tantiworawit, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna L. Forrest, MD

Blood (2011) 118 (21): 1694.

https://doi.org/10.1182/blood.V118.21.1694.1694

Published: 2011

Journal Articles

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Derek To, Dawn Warkentin, BSc(Pharm), PharmD, Raewyn Broady, MBChB, FRACP, Kevin Song, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, John D. Shepherd, MD, FRCPC, Donna E. Hogge, MD, PhD, Cynthia L. Toze, MD, FRCPC, Sujaatha Narayanan, MD, Yasser Abou Mourad, MD, Heather J. Sutherland, MD, PhD, FRCPC, Maryse M. Power, MD, FRCPath

Blood (2011) 118 (21): 4567.

https://doi.org/10.1182/blood.V118.21.4567.4567

Published: 2011

Journal Articles

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Winnie Ma, BSc(Pharm), Dawn Warkentin, BSc(Pharm), PharmD, Janice Yeung, BSc(Pharm), PharmD, John D Shepherd, MD, Yasser Abou Mourad, MD, Clayton Smith, MD, FRCPC, Kevin Song, MD, Donna E. Hogge, MD, PhD, Michael J Barnett, BMBS, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, Cynthia L. Toze, MD, FRCP(C), Heather J. Sutherland, MD, PhD, Donna L. Forrest, MD, Sujaatha Narayanan, MD, Maryse M Power, MD

Blood (2009) 114 (22): 1136.

https://doi.org/10.1182/blood.V114.22.1136.1136

Published: 2009

Journal Articles

Short Progression Free Survival Post Non-Myeloablative Sibling Allogeneic Stem Cell Transplantion for Multiple Myeloma.

Kevin Song, MD, Heather J. Sutherland, MD, PhD, John D. Shepherd, MD, Yasser Abou Mourad, MD, Michael J Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Sujaatha Narayanan, MBBS, Stephen H. Nantel, MD, Maryse M Power, MB, Cynthia L. Toze, MD, Clayton Smith, MD, Thomas J. Nevill, MD

Blood (2009) 114 (22): 4323.

https://doi.org/10.1182/blood.V114.22.4323.4323

Published: 2009

NARROW

Outcome of Hodgkin Lymphoma after Progression Following Autologous Stem Cell Transplantation

Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes

Pediatric-Based Versus Adult Treatment Protocols in Young Adults (18-40 years) with Standard Risk Acute Lymphoblastic Leukemia: The BC Cancer Agency Experience

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors

Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation

Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Safety and Efficacy of Posaconazole for the Treatment of Invasive Fungal Infections After Failure of One Prior Line of Therapy

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Short Progression Free Survival Post Non-Myeloablative Sibling Allogeneic Stem Cell Transplantion for Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only